Supreme Court Pauses Restrictions on Abortion Pill Access

The US Supreme Court has issued a temporary stay on a federal appeals court ruling that sought to ban telemedicine and mail-order prescriptions for the abortion pill mifepristone. This one-paragraph order, released late Thursday, ensures that mifepristone remains accessible via telehealth and mail for the foreseeable future, even in states with strict abortion bans. The decision halts the Fifth Circuit Court of Appeals' earlier attempt to suspend FDA rules established during the Biden administration, which had removed in-person dispensing requirements. The case has generated significant legal and political tension since the overturning of Roe v. Wade. While Justices Samuel Alito and Clarence Thomas dissented, arguing the move undermines state laws and citing the Comstock Act, the majority chose to maintain current access levels. This ruling provides temporary relief to abortion providers and patients amidst ongoing nationwide legal battles over reproductive rights. It highlights the continuing conflict between federal regulatory authority and state-level restrictions following the Dobbs decision, affecting millions of Americans who rely on medication abortions.